miRNA Identified That Plays Role in Milk Allergy

This article originally appeared here.
Share this content:
miRNA Identified That Plays Role in Milk Allergy
miRNA Identified That Plays Role in Milk Allergy

WEDNESDAY, Sept. 13, 2017 (HealthDay News) -- MiR-193a-5p is a post-transcriptional regulator of interleukin-4 (IL-4) expression and could have a role in children's cow's milk allergy (CMA), according to a study published online Aug. 30 in Allergy.

Valeria D'Argenio, M.D., from the University of Naples Federico II in Italy, and colleagues collected peripheral blood mononuclear cells from children aged 4 to 18 months, including 10 CMA patients, nine CMA patients who outgrew CMA, and 11 healthy controls. Next-generation sequencing was used to create small RNA libraries, as well as a functional assessment of IL-4 expression.

The researchers found that among the micro RNAs (miRNAs) differently expressed, two were up-regulated and 14 were down-regulated in children with active CMA versus healthy controls. In children with active CMA, miR-193a-5p was the most down-regulated miRNA, compared to healthy controls. The predicted targets of miR-193a-5p were up-regulated in CMA patients. A significant up-regulation of IL-4 mRNA and its protein expression occurred when peripheral blood CD4+ T cells were transfected with a miR193a-5 inhibitor. Levels of miRNA-193a-5p and expression of its related targets in children who outgrew CMA were similar to that seen in healthy controls.

"This miRNA could be a novel diagnostic and therapeutic target for this common form of food allergy in childhood," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

Amount of Opioids Prescribed After Hospital Discharge Varies

Amount of Opioids Prescribed After Hospital Discharge Varies

45.6 percent of patients using no opioids 24 hours predischarge were prescribed opioids at discharge

Observation Care Cost Saving in Commercially-Insured Patients

Observation Care Cost Saving in Commercially-Insured Patients

Total, out-of-pocket spending considerably lower for observation care; both increased from '09 to '13

Disrupted Sleep Linked to Increased Amyloid- Production

Disrupted Sleep Linked to Increased Amyloid-β Production

Sleep deprivation tied to increased overnight amyloid-β-38, -40, -42 levels by 25 to 30 percent

is free, fast, and customized just for you!

Already a member?

Sign In Now »